BCDA
BioCardia, Inc.
Key Financials
Operating Income
$-8278000
↓ 3.5%
Net Income
$-8228000
↓ 3.5%
Revenue
$479000
↓ 16.8%
Gross Profit
$62000
↑ 416.7%
Total Assets
$3.4M
↓ 8.4%
EPS (Diluted)
$-0.21
N/A
Shareholders' Equity
$895000.00
↑ 6.9%
Total Liabilities
$2.5M
↓ 12.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/1/2026 | View on SEC |
| 4 | 9/30/2026 | View on SEC |
| 4 | 9/23/2026 | View on SEC |
| 8-K | 9/23/2026 | View on SEC |
| 8-K | 9/21/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| 8-K | 8/24/2026 | View on SEC |
| 8-K | 8/21/2026 | View on SEC |
| 4 | 8/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCDA |
| Company Name | BioCardia, Inc. |
| CIK | 925741 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-226-0123 |